NLRP3 and Alzheimer disease: In a mouse model of AD, NLRP3 or caspase-1 deficiency facilitate microglia to gain an anti-inflammatory phenotype, enhance amyloid-β clearance, decrease amyloid-β deposition and protect mice from the loss of spatial memory [123].